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Abstract
Background: Bipolar disorder patients often display abnormalities in circadian rhythm, and they are sensitive to irregular
diurnal rhythms. CRY2 participates in the core clock that generates circadian rhythms. CRY2 mRNA expression in blood
mononuclear cells was recently shown to display a marked diurnal variation and to respond to total sleep deprivation in
healthy human volunteers. It was also shown that bipolar patients in a depressive state had lower CRY2 mRNA levels,
nonresponsive to total sleep deprivation, compared to healthy controls, and that CRY2 gene variation was associated with
winter depression in both Swedish and Finnish cohorts.
Principal Findings: Four CRY2 SNPs spanning from intron 2 to downstream 39UTR were analyzed for association to bipolar
disorder type 1 (n=497), bipolar disorder type 2 (n=60) and bipolar disorder with the feature rapid cycling (n=155) versus
blood donors (n=1044) in Sweden. Also, the rapid cycling cases were compared with bipolar disorder cases without rapid
cycling (n=422). The haplotype GGAC was underrepresented among rapid cycling cases versus controls and versus bipolar
disorder cases without rapid cycling (OR=0.7, P=0.00620.02), whereas overrepresentation among rapid cycling cases was
seen for AAAC (OR=1.321.4, P=0.0320.04) and AGGA (OR=1.5, P=0.05). The risk and protective CRY2 haplotypes and
their effect sizes were similar to those recently suggested to be associated with winter depression in Swedes.
Conclusions: We propose that the circadian gene CRY2 is associated with rapid cycling in bipolar disorder. This is the first
time a clock gene is implicated in rapid cycling, and one of few findings showing a molecular discrimination between rapid
cycling and other forms of bipolar disorder.
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Introduction
Chryptochrome 2 (CRY2) is a central component in the
mammalian core circadian pathway that orchestrates rhythms that
approximate the 24-hour day-night cycle [1]. Mood disorders often
display disturbances in circadian rhythms that are manifested as
abnormalities in sleep stage and various physiological domains,
clinical efficacy of sleep deprivation [2,3], and a molecular effect on
thecircadian clockbylithium [4], whichiscommonly prescribed for
bipolar disorder. CRY2 mRNA expression in blood mononuclear
cells was recently shown to display a marked diurnal variation and
response to total sleep deprivation in healthy human volunteers. It
was also shown that bipolar patients in a depressive state had lower
CRY2 mRNA levels compared to healthy controls, and were
nonresponsive to total sleep deprivation, and that CRY2 gene
variation wasassociated with winterdepression inboth Swedish and
Finnish cohorts. The four-SNP risk and protective haplotypes
spanned from CRY2 intron 2 to downstream the 39UTR and
overlapped between the Swedish and the Finnish cohorts [5].
Bipolar disorder is characterized by episodes of the mood states
mania/hypomania, depression, or mixed states at rates that vary
markedly between and within individuals. Rapid cycling, defined
according to DSM-IV as four or more mood episodes in any
combination or order within any year in the course of the illness, is
a severe and often treatment refractory form of bipolar disorder
with tendency for more depressive than manic episodes [6,7].
Rapid cycling has been associated to less favorable outcome with
more pronounced functional impairment [8,9], higher risk for
suicide attempts and a higher rate of alcohol abuse [7]. Therefore,
several researchers have tried to define rapid cycling as a distinct
sub-group of bipolar disorder.
It is well known that bipolar patients are sensitive to irregular
diurnal rhythms, and that a regular diurnal rhythm is one of the
most important and effective focuses to reduce recurrence of
bipolar episodes [10,11]. Bipolar disorder cases are heterogeneous
with regard to underlying genetic risk factors [12]. To possibly
reduce the complexity of the genetic underpinnings we focused on
rapid cycling, thus studying bipolar disorder patients with the
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‘‘diurnal system’’. We tested the hypothesis that CRY2 gene
variation is associated with bipolar disorder, and rapid cycling in
particular, in a Swedish bipolar cohort. The same four SNPs as
analyzed previously [5] were analyzed in 557 bipolar cases and
1044 population controls.
Results
The four CRY2 SNPs rs10838524, rs7123390, rs10838527 and
rs3824872, spanning from intron 2 to downstream 39UTR, were
analyzed for allelic association to bipolar disorder type 1, bipolar
disorder type 2 and bipolar disorder with the feature rapid cycling
versus population controls being anonymous blood donors (ABD).
The A allele of rs10838524 was significantly overrepresented
among bipolar disorder cases with rapid cycling compared to ABD
controls (OR=1.42, CI=1.1021.83, P=0.0076), also after
Bonferroni correction (cut-off for significance at P=0.050/(3
case-control sets*2 SNP groups (defined by D’.0.80))=0.0083)
(Table 1). To follow-up the association to rs10838524 a case-case
design was performed. Rapid cycling bipolar cases (RC-BP) were
compared with cases without rapid cycling (non-RC-BP). The
results confirmed the association to rs10838524 (OR=1.48,
CI=1.1221.96, P=0.0055) (Table 1). Neither bipolar disorder
type 1 or bipolar disorder type 2 showed suggestive allelic
association to any of the SNPs and were therefore not further
analyzed (OR=1.0221.26 and 1.0121.27, respectively, P.0.05).
There was a significant dosage effect (trend) in the association
between the A allele of rs10838524 and rapid cycling (P=0.0076)
and this allele increased the risk for rapid cycling both in a
homozygote and a heterozygote form (that is dominant model)
compared to ABD controls (OR=1.79, P=0.0081) (Table 2).
Also, rapid cycling cases compared to non-RC-BP showed a trend
(P=0.0041) and dominant model association (OR=1.80,
P=0.0098) (Table 2). For the SNP rs3824872 there was no
difference in allele frequency between rapid cycling cases and
ABD controls or non-RC-BP, however the AA genotype was
suggestively associated with a risk for rapid cycling in both the
case-control and the case-case sample sets (OR=2.16, P=0.025
and OR=2.38, P=0.026, respectively). Likewise, rs10838527 G
carriers were borderline overrepresented among cases compared
to ABD controls (OR=1.56, P=0.046) (Table 2).
Pairwise linkage disequilibrium (LD) measure D’ was 1.00
between all SNPs except between rs10838524 and rs7123390
where D’ was 0.67. This overall high LD indicated that the SNPs
spanning from rs10838524 to rs3824872 were tightly linked, thus
all four SNPs were included in the haplotype block analyzed. Five
haplotypes with frequency .1% were identified. The haplotype
GGAC, including the protective alleles G from rs10838524, A
from rs10838527 and C from rs3824872, was found less frequently
in rapid cycling cases compared to ABD controls (OR=0.75,
P=0.024) and compared to non-RC-BP (OR=0.67, P=0.0055)
(Table 3). The haplotype AAAC, including the risk allele
rs10838524 A was found suggestively more frequent in rapid
cycling cases in both the case-control (OR=1.34, P=0.043) and
in the case-case material (OR=1.41, P=0.033). Also, the
haplotype AGGA was suggestively overrepresented in rapid
cycling cases versus ABD controls (OR=1.55, P=0.048) (Table 3).
Discussion
This study gives evidence that the CRY2 gene is associated with
rapid cycling in bipolar disorder in Sweden. This is the first
independent replication of the recent findings from gene
expression analysis in white Americans that CRY2 is associated
to bipolar disorder, and from haplotype frequency analysis in
Swedes and Finns that CRY2 is associated to winter depression [5].
Hence, the present finding reinforces the significance of the
previous reports implicating CRY2 in mood disorder in humans
[5], and in rodent model [13].
The risk and protective CRY2 haplotypes AGGA and GGAC,
respectively, that were here indicated to be associated with rapid
cycling in Swedish bipolar patients, were identical to those recently
suggested to be associated with winter depression in Swedish
patients, with similar case and control haplotype frequencies, and
thereby similar effect sizes, between the two studies [5]. On single
SNP-level, the A allele of the most upstream SNP studied,
rs10838524, was associated with rapid cycling, similarly as with
winter depression among Swedes. Similarly, the single-SNP results
for rs10838527 and rs3824872 were in agreement between the two
Table 1. Allele frequency association results for rapid cycling.
SNP Location Alleles Control set MAF: A/U OR [95% CI]
a P-value
a
Empirical
P-value
rs10838524 Intron 2 A*/G ABD 0.52/0.44 1.42[1.1021.83] 0.0076 0.022
Non-RC-BP 0.52/0.43 1.48[1.1221.96] 0.0055 0.018
rs7123390 Intron 8 A/G* ABD 0.31/0.28 1.29[0.9321.58] 0.16 0.26
Non-RC-BP 0.31/0.26 1.29[0.9621.74] 0.087 0.25
rs10838527 39UTR G/A* ABD 0.11/0.079 1.51[0.9822.33] 0.060 0.070
Non-RC-BP 0.11/0.089 1.26[0.8121.96] 0.31 0.075
rs3824872 Downstream 39UTR A/C* ABD 0.23/0.21 1.51[0.8621.56] 0.32 0.37
Non-RC-BP 0.23/0.20 1.19[0.8721.63] 0.27 0.36
Alleles, minor allele first.
*Ancestral allele in CEU population data (CEPH (Utah residents with ancestry from northern and western Europe)) from www.hapmap.org.
MAF, Minor allele frequencies for the affecteds (A) and unaffecteds (U).
ABD, anonymous blood donors.
Non-RC-BP, bipolar disorder patients without rapid cycling.
Odds ratio (OR), the proportion of minor versus major allele among affecteds (A)/proportion of minor versus major allele among unaffecteds (U).
aLogistic regression with gender as covariate was used.
Empirical P-value (EMP1), Point-wise P-value from 10,000 permutations.
doi:10.1371/journal.pone.0012632.t001
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reported Finnish winter depression vulnerability locus [5]. The
rapid cycling risk and protective haplotypes AAAC and GGAC,
respectively, were the opposite, that is protective and risk
haplotypes, in the Finnish winter depression sample. This indicates
allelic heterogeneity for the CRY2 functional variation between the
Swedish and Finnish populations.
Involvement of circadian gene variation in bipolar disorder is in
agreement with the findings of circadian misalignments (i.e. the
sleep-wake cycle is no longer in phase with the circadian rhythms)
in patients with bipolar disorder [14]. Further, it is in agreement
with the treatment efficacy of lithium targeting the circadian clock
regulator glycogen synthase kinase 3b (GSK3b) [4], with findings
of low melatonin levels in patients with bipolar and depressive
disorder [15], and with increased melatonin suppression by light in
bipolar disorder patients [16]. Melatonin appears to adjust the
timing of circadian rhythm information, and has been suggested to
be a marker for circadian rhythm phase and period [17]. In the
circadian rhythm mainly phase advances (the location within a
cycle at a particular time) has been reported in bipolar disorder,
but also delays and reduced amplitudes (intensities of the
oscillations) have been reported in mood disorder [18–20].
Therefore, the circadian misalignment may contribute to the
pathogenesis of mood disorders. Both phase shifts and amplitude
attenuations have been hypothesized to contribute to the
pathogenesis [21].
Chryptochromes (CRY1 and CRY2) have a role in photore-
ception and in the core circadian clock itself. Biochemical and
photochemical properties of human CRY2 have been described
[22], and functional studies of Cry2 have been performed in
rodents. However, the understanding of CRY2 regulation and
CRY2 function is still limited. Findings point to that CRY2 is
Table 2. Genotype association analysis results for rapid cycling.
SNP
Control
set
Cases aa/
ab/bb (%)
Cases
n
Controls aa/
ab/bb (%)
Controls
n
Cochran-Armitage
trend P- value
a P-valuea OR[95% CI]
Dominant model
b Recessive model
b
rs10838524 A/G ABD 25/54/21 145 20/50/31 914 0.0076 0.0081 1.79[1.1622.75] 0.10 1.42[0.9322.16]
Non-RC-BP 25/54/21 145 18/50/33 396 0.0041 0.0098 1.80[1.1522.85] 0.060 1.55[0.9822.46]
rs7123390 A/G ABD 11/40/49 146 9/38/53 928 0.16 0.23 1.24[0.8721.78] 0.26 1.39[0.7822.49]
Non-RC-BP 11/40/49 146 6/39/55 398 0.12 0.24 1.26[0.8621.84] 0.067 1.85[0.9623.56]
rs10838527 G/A ABD 0/22/78 147 0/15/84 945 0.039 0.046 1.56[1.0122.42] 1.00
Non-RC-BP 0/22/78 147 1/15/83 403 0.059 0.15 1.42[0.8822.27] 1.00
rs3824872 A/C ABD 9/28/63 146 4/33/63 943 0.32 0.86 1.03[0.7121.49] 0.025 2.16[1.1024.22]
Non-RC-BP 8.9/28/63 146 4/32/64 400 0.26 0.77 1.06[0.7221.57] 0.026 2.38[1.1125.08]
ABD, anonymous blood donors.
Non-RC-BP, bipolar disorder patients without rapid cycling.
Alleles, minor allele (a) first.
aLogistic regression with gender as covariate was used.
bof minor allele.
Odds ratio (OR), the proportion of minor versus major allele among affected (A)/proportion of minor versus major allele among non-affected (U).
doi:10.1371/journal.pone.0012632.t002
Table 3. Haplotype association analysis results for rapid cycling.
SNPs Haplotype Control set Frequency cases Frequency controls OR
a P-value
a
rs10838524-rs7123390-
rs10838527-rs3824872
AGGA ABD 0.11 0.078 1.55 0.048
Non-RC-BP 0.11 0.090 1.26 0.30
AGAA ABD 0.12 0.13 0.94 0.74
Non-RC-BP 0.12 0.11 1.1 0.65
AAAC ABD 0.28 0.23 1.34 0.043
Non-RC-BP 0.28 0.22 1.41 0.033
GAAC ABD 0.038 0.047 0.80 0.49
Non-RC-BP 0.039 0.039 0.95 0.88
GGAC ABD 0.45 0.51 0.75 0.024
Non-RC-BP 0.45 0.54 0.67 0.0055
ABD, anonymous blood donors.
Non-RC-BP, bipolar disorder patients without rapid cycling.
Odds ratio (OR), the ratio specific haplotype versus all other haplotypes among the cases, relative to the ratio specific haplotype versus all other haplotypes among the
controls.
aLogistic regression with gender as covariate was used.
doi:10.1371/journal.pone.0012632.t003
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evening oscillator (light to dark transition) whereas CRY1 is
involved in the morning oscillator [26]. In support, deletion of
Cry2 gene in mice prolonged the circadian period by approxi-
mately 48 min (from 23.7 to 24.5 hours) [27], and Cry2 null
mutants were more accelerated by light exposure than Cry1 null
mutants [28]. There are reports that support a disturbed evening
oscillator, in line with a possible CRY2 dysfunction, in bipolar
disorder type 1 [16] and winter depression [29], and there are data
that indicate intact morning oscillator in patients with bipolar
disorder [30] and in winter depression patients [31].
Lithium maintenance treatment is the drug of choice in
especially bipolar disorder type 1, but rapid cycling patients often
need a combination with valproic acid or other antiepileptic drugs.
There are concerns about the risk to induce mood switches with
antidepressant therapy. Therefore most guidelines recommend
clinicians to avoid such medication for patients with rapid cycling.
Currently, a major problem is the lack of tools to predict this form
of illness. Medical treatment in our patients was clinically defined,
thus no conclusions about treatment effects could be drawn.
The present finding, in particular in the case-case analysis,
indicates that rapid cycling has some molecular distinction from
bipolar disorder without rapid cycling. Several studies have tried
to define rapid cycling as a distinct sub-group of bipolar disorder.
Predictors such as family aggregation, early age at onset, and
gender have been discussed, but the only consistent finding is a
modest overrepresentation of women suffering from rapid cycling
[7,32]. From findings in molecular genetic association studies,
there are some candidate genes for rapid cycling including COMT
[33], 5-HTT [34,35] and BDNF [36,37], but these findings are
inconsistent and are in need for replication. An alternative to
regard rapid cycling as a categorical dimension, is to consider the
frequency of bipolar disorder episodes as a continuum where rapid
cycling is a more severe course, which might be a result of a higher
genetic loading. However, even though the CRY2 SNPs
rs10838524 and rs3824872 in our study appeared not to be
associated with bipolar disorder type 1, we cannot exclude the
possibility of a true association for in particular the CRY2 SNPs
rs7123390 and rs10838527 to bipolar disorder. Our inability to
detect an association could reflect lack of power. Likewise, due to
lack of power true single SNP association to rapid cycling for any
of the SNPs without suggestive association cannot be excluded.
Also, the bipolar disorder type 2 sample size was small.
Furthermore, the anonymous blood donors (ABD) were popula-
tion controls not screened for history of mental disorder. On the
other hand, bipolar disorder cases are heterogeneous with regard
to clinical symptoms and severity, and to genetic underpinnings
[12]. This heterogeneity seems to pertain also to circadian rhythm
abnormalities, exemplified by that melatonin suppression by light
was seen in some but not other studies of bipolar disorder patients
[16].
Circadian gene polymorphisms in CLOCK and VIP [38,39], and
NR1D1, ARNTL and PER3 [40–43] have previously been
associated to human bipolar disorder. Moreover, ARNTL, RORA,
RORB and RXRG were associated with bipolar disorder in a meta-
analysis integrating data from genome-wide association studies
and human and animal model expression studies [44,45]. RORB
gene variation was found associated with bipolar disorder in
children, which in general have a more rapidly cycling clinical
presentation than adults [46]. Also, knock-out of DBP in mouse
resulted in bipolar disorder with both phases [47].
Our patient material has not yet been analyzed for population
stratification since only few genetic variations have been studied.
However, a study of samples collected 2003 showed that the
Swedish population has no strong internal genetic borders [48].
The vast majority of cases and controls in this CRY2 study were
living in Stockholm. In conclusion, this is the first report of genetic
association between the circadian gene CRY2 and a severe form of
human bipolar disorder. It is also the first time a clock gene is
implicated in rapid cycling, and one of few findings showing a
molecular discrimination between rapid cycling and other forms of
bipolar disorder. The finding is in line with a previous report on
CRY2 in human mood disorder, thus strengthening the evidence
for the contribution of circadian gene variations to mood
disorders.
Materials and Methods
Subjects and DNA
Written informed consent was obtained from the subjects. The
study was approved by the Regional Ethical Review Board at
Karolinska Institutet in Stockholm.
Patients (n=577) were recruited from clinics in Stockholm
County (n=529), Southern Sweden (Ska ˚ne n=41), and Northern
Sweden (Va ¨sternorrland n=7). They were diagnosed with bipolar
disorder type 1 (n=497, 43% men) or bipolar disorder type 2
(n=60, 36% men), or bipolar disorder unknown type (n=20). All
medical records were studied, and focusing on the most severe
manic episode the DSM-IV manic symptoms as well as rapid
cycling and mixed episodes were registered. In order to complete
the information participants were then interviewed over telephone
by a psychiatrist or a special trained psychiatric nurse using the
module for mania in Schedules for Clinical Assessment in
Neuropsychiatry (SCAN) [49]. Individuals were excluded if mania
was the result of alcohol or drug abuse, medication or somatic
disease, as well as if close relatives were already included. The
phenotypes rapid cycling (n=155, 35% men), mixed episodes, the
age of onset of mania as well as depression were registered.
Population control DNA samples were collected from anonymous
blood donors (ABD, n=1044, 59% men) at Karolinska University
Hospital, Stockholm, Sweden. Peripheral blood samples were
collected and genomic DNA was extracted by SDS-urea by
standard procedures and quantified by nano-drop. A previous
study of samples collected in 2003 showed that the Swedish
population had no strong internal genetic borders [48].
To analyze for genetic association to CRY2, a case-control
design was applied: bipolar disorder type 1 versus ABD, bipolar
disorder type 2 versus ABD, and bipolar disorder with rapid
cycling versus ABD. In addition, an analysis using the case-case
design was performed: bipolar disorder with rapid cycling versus
bipolar disorder without rapid cycling (non-RC-BP, n=422, 43%
men) was used.
Genotyping
We selected four SNPs in the CRY2 gene: rs10838524,
rs7123390, rs10838527 and rs3824872. These four SNPs have
in a previous study been associated with vulnerability for
depression [5]. All SNPs were genotyped on a 7900HT Fast
Real-Time PCR System Instrument by using allele-specific
Taqman MGB probes labeled with fluorescent dyes FAM and
VIC (Applied Biosystems), according to manufacturer’s protocols.
Allelic discrimination was performed with the ABI PRISM
7900HT SDS and the SDS 2.2.1 program (Applied Biosystems).
Statistical analyses
The three case-control sets and one follow-up case-case sample
set were analyzed for allele frequency differences for the four CRY2
SNPs using logistic regression with gender as covariate. Permu-
CRY2 and Rapid Cycling
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obtain empirical significance values. Suggestive allele frequency
difference (P,0.05) was found for rapid cycling versus ABD and
rapid cycling versus non-RC-BP. These two sample sets were
further analyzed for genotype and haplotype frequency differenc-
es, with gender used as covariate. P-values reported are
uncorrected for multiple testing. P,0.05 was regarded as
suggestively significant, whereas the Bonferroni corrected thresh-
old P,0.0083 (0.050/(3 case-control sets*2 SNP groups (defined
by D’.0.80))) was regarded as significant (Bonferroni correction
considering the partial LD between markers [50,51]). In the
haplotype analysis all four SNPs were included since the pairwise
linkage disequilibrium (LD), calculated between all four SNPs,
were in strong LD. Allele, genotype and haplotype frequency
difference tests as well as LD were calculated using the PLINK
program, version 1.04 [52]. The trend tests with gender as
covariate were performed in the Rcmdr package [53]. All four
SNP fulfilled the criteria for Hardy-Weinberg equilibrium (HWE)
among the controls (P.0.05). For genotyping quality control, 10%
of the samples were genotyped twice and on average nine negative
controls per 384 plate were used. The overall genotyping success
was 91%. The power was ,0.55 to detect an association between
rapid cycling and rs10838524 for an allelic and a dominant model
test, and between rapid cycling and rs3824872 for a recessive and
a genotypic (2 df) model at a ´ =0.05 using ABD controls, whereas
the power was lower for the other two SNPs. The power to detect
association for bipolar disorder type 1 to rs10838524 and
rs3824872 at above mentioned models, assuming similar effect
size as found for rapid cycling, was .0.85 at a ´ =0.05, whereas it
was far below 0.80 for the other two SNPs (http://pngu.mgh.
harvard.edu/ ˜purcell/gpc/cc2.html).
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